logo
"I can't even tell you how important this is" — expert reveals why 90% of women don't know they have sleep apnea

"I can't even tell you how important this is" — expert reveals why 90% of women don't know they have sleep apnea

Yahoo19-07-2025
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Sleep apnea is a condition where your breathing temporarily stops or is disrupted during the night. When you experience this, your brain automatically wakes you from your slumber. You might let out a loud snore, a snort or make a gasping sound in order to breathe again.
In women, snoring can be much less pronounced so it's not as easy to tell from this symptom alone. Women are more likely to experience daytime sleepiness, impaired focus and mood changes.
This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the signs are more subtle, research suggests as many as 90% of women who have sleep apnea may be unaware they have it.
We've chatted with a sleep medicine specialist and a clinical sleep educator to find out more about this important sleep health topic for women.
What is sleep apnea?
'Sleep apnea is a condition where breathing stops or is disrupted at night time, eroding an individual's quality of sleep,' explains Dr Anthony Izzo, a board-certified neurologist and sleep medicine specialist who is Sleep Center Medical Director at St Vincent Hospital.
'Each time breathing stops, the brain receives an alert about low oxygen, and it's forced from a deep stage of sleep to a light stage to brief wakefulness in order to address the alert.'
There are two main types of sleep apnea: obstructive and central. Obstructive sleep apnea (OSA) is much more common says Dr Izzo.
'OSA occurs because tissues in the top of the airway, behind the nose and mouth, collapse down when the muscles that keep them up relax during sleep as this blocks the flow of air to the lungs,' he explains.
'Central sleep apnea happens when the brain doesn't create the right signal to breath,' he adds.
'It's associated with underlying medical conditions like congestive heart failure, lung diseases, or long-term use of opioid medications. But we don't see much of this in clinical practice.'
Does sleep apnea affect women differently to men?
Yes, it very much does. Women are more likely to experience subtle symptoms such as mood changes and not being able to focus or concentrate well day after day.
This means diagnosis can be delayed or the condition can be mistaken for the symptoms of the menopause or depression.
'I can't even tell you how important this is as sleep apnea in women often goes undiagnosed,' explains Lauri Leadley, clinical sleep educator, president and founder of Valley Sleep Center.
'The symptoms are sometimes attributed to general life challenges such as stress, and the menopause. But the truth is sleep apnea in women is overlooked.'
Symptoms of sleep apnea in women
Although men and women do experience some similar symptoms of sleep apnea, like snoring, there are also differences. Women are more likely to experience these subtle signs.
Frequent morning headaches
If you're prone to starting your mornings with a dull headache, this could be a tell-tale sign. Morning headaches that are present as soon as you wake up are associated with obstructive sleep apnea.
A 2015 study published in the Journal of Headache and Pain looked at 48 people who had been diagnosed with OSA and experienced morning headaches. They found 25% had morning headaches for more than 15 days per month.
Mood changes
Obstructive sleep apnea and its impact on sleep quality can also worsen feeling anxious, irritable and impatient. It can affect your mood and could also lead to depression.
'Sometimes when your symptoms aren't severe, it can be easy to write them off as nothing to worry about,' Lauri explains.
'But my advice is to be mindful about frequent mood swings that regularly leave you feeling anxious or low. No, it is not just you being bitchy or hard to deal with.'
Forgetfulness and fuzzy thinking
Although women with sleep apnea are less likely to experience loud snoring as they suddenly wake during the night, the condition can still disrupt their sleep quality.
Unsurprisingly, this has a knock-on impact on your cognitive health. You may have difficulty thinking clearly, and your attention, focus and concentration can also be impaired.
'Having trouble with focus or memory throughout the day may be the only symptoms a woman with sleep apnea experiences, even though they might not think it's related,' explains Dr Izzo.
Dry mouth in the morning
Regularly waking up with a dry mouth or sore throat can also indicate obstructive sleep apnea. It's regarded as a key symptom in OSA and it's caused by your breathing being impaired throughout the night.
This can lead to a drop in oxygen concentration as a result of open-mouth breathing. Your mouth then becomes dry and you could also be more likely to experience morning headaches too.
Needing to go the toilet more at night
'Frequent urination during the night can also be a sign of sleep apnea in women,' says Lauri.
As OSA causes frequent sleep disruptions, you may find this makes you want to go to the toilet more during the night.
If you find you're waking to urinate several times at night, it could still indicate OSA (even if it seems like a separate and unrelated issue).
What causes sleep apnea in women?
Some of the causes of OSA are similar for both men and women. For example, weight gain and the shape or anatomy of the upper airway. With central sleep apnea, it's often associated with underlying medical conditions such as congestive heart failure and lung diseases.
We also see sleep apnea worsen during menopause
Hormonal changes can play a key role in the onset of sleep apnea in women as Dr Izzo explains.
'We know that sleep apnea typically can happen in patients without a prior history, starting in the second trimester of pregnancy. It can worsen in severity throughout the second and third trimesters,' he says.
'We also see sleep apnea worsen during menopause, although typically patients will have already been diagnosed pre-menopause in this situation,' he adds. 'Menopause is often associated with weight gain, which in turn, worsens sleep apnea severity.'
How women can treat sleep apnea
While the symptoms of sleep apnea may present differently, the solutions remain largely the same. But it's different for everyone, so be sure to speak directly with a physician. Below are common treatments for sleep apnea.
Lifestyle changes
For mild sleep apnea, lifestyle changes, such as quitting smoking and losing weight and improving sleep hygiene can be very beneficial in treating the condition.
If you also have allergies which affect your breathing such as allergic rhinitis, your physician or sleep specialist could suggest a treatment that could help to mitigate your allergy symptoms.
Keeping regularly active is good for your lungs as well as your general health and could help to reduce the number of breathing pauses you experience while you sleep.
CPAP mask
If lifestyle changes don't fully help to treat your sleep apnea symptoms, you may be provided with a continuous positive airway pressure (CPAP) machine and mask.
'A CPAP mask is considered first line for sleep apnea as it's effective for all severities of OSA,' says Dr Izzo.
The machine works by delivering air at pressure through a mask that is placed over your nose and mouth. It can help to keep your airways open to prevent impaired breathing while you sleep.
Mouthguard
Another treatment alternative for mild to moderate sleep apnea is an oral device such as a sleep apnea mouthguard that you would wear at bedtime. These are designed to keep your throat open while you sleep to lessen symptoms.
They work by preventing your tongue from blocking your throat and this can help to prevent snoring. Another option is a mouthguard that works slightly differently by moving your lower jaw forward to keep your throat open.
These oral devices are easier to use but you may not find them comfortable, and they may not work for everyone.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

More Data Cement COVID's Impact on Patients With Cancer
More Data Cement COVID's Impact on Patients With Cancer

Medscape

time28 minutes ago

  • Medscape

More Data Cement COVID's Impact on Patients With Cancer

TOPLINE: New data confirm the impact COVID infection can have on patients with cancer and identified several risk factors associated with hospitalization and death. Receipt of chemotherapy as well as a baseline history of stroke, atrial fibrillation, or pulmonary embolism were each associated with nearly double the risk for COVID-related hospitalization. Prior vaccination halved this risk. Older age and earlier hospitalization were associated with a greater risk for death. METHODOLOGY: Patients undergoing active cancer treatment are at increased risk for severe COVID-19 due to immunosuppression, but risk factors for hospitalization and death are not well-defined. Researchers conducted a prospective cohort study involving 1572 patients with cancer (median age, 60 years; 53.4% women), enrolled within 14 days of a positive SARS-CoV-2 test; participants had received active treatment for cancer within 6 weeks before testing or had undergone prior stem cell transplant or CAR T-cell therapy. Patient screening and enrollment took place between May 2020 and February 2022. Treatments included chemotherapy (34.3%), targeted therapy (27.7%), and immunotherapy (10.6%). Breast (23.6%) and lung (13.9%) cancers were the most common cancer types. Overall, 64% of participants had metastatic disease, and at enrollment, 64% had not received a COVID vaccine. Study outcomes were COVID-related hospitalization or death. Risk factors for hospitalization and for death among hospitalized patients were evaluated separately. TAKEAWAY: At 90 days after an initial positive test, COVID-related mortality was 3% and remained stable at subsequent follow-ups. The highest incidence occurred in patients with lymphoma, followed by those with acute leukemia or lung cancer; the lowest incidence occurred in those with other types of solid tumors and blood cancers. Hospitalization for COVID-19 occurred in 18.4% of patients within 90 days of enrollment. The risk for hospitalization was elevated among patients who received chemotherapy (hazard ratio [HR], 1.97) and those with a history of stroke, atrial fibrillation, and pulmonary embolism (HR, 1.78). Vaccination prior to infection reduced the risk for hospitalization by nearly half (HR, 0.52). Hospitalization for COVID-19 within 30 days of infection was associated with an increased risk for death (HR, 14.6). Among patients hospitalized for COVID within 30 days, age 65 years or older was the only significant predictor of COVID-specific death (HR, 3.49). Over the 2-year follow-up, there were 1739 disruptions to cancer treatment; 50.7% of these were attributed to COVID-19, and most occurred within 30 days of a positive test. IN PRACTICE: 'The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as associated with COVID-19 severity,' the authors of the study wrote, noting that the results 'showed that COVID-19 had a significant impact on patients with cancer, including hospitalization, treatment disruptions, and death.' SOURCE: This study, led by Brian I. Rini, MD, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, was published online in JAMA Oncology. LIMITATIONS: Information on specific strains was not available. This study lacked a control group of patients without COVID-19, which limited causal inference. Additionally, as participants were enrolled through the National Cancer Institute trial networks, generalizability to a broader population could be limited. DISCLOSURES: This study was funded in part by the Coronavirus Aid, Relief, and Economic Security Act and the National Cancer Institute National Clinical Trials Network, Experimental Therapeutics Clinical Trials Network, and Community Oncology Research Program grants via the U10 funding mechanism. Several authors declared receiving grants and/or personal fees and having other ties with various sources. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

MrFluffyFriend Launches XXXXL Calming Dog Bed for Large and Anxious Dogs
MrFluffyFriend Launches XXXXL Calming Dog Bed for Large and Anxious Dogs

Yahoo

timean hour ago

  • Yahoo

MrFluffyFriend Launches XXXXL Calming Dog Bed for Large and Anxious Dogs

Over 600,000 dogs sleep better already — now available in 48 inch (120cm) & 56 inch (140cm) with up to 60% off and free shipping on Image by MrFluffyFriend LOS ANGELES, July 27, 2025 (GLOBE NEWSWIRE) -- MrFluffyFriend, a fast-growing U.S. pet wellness brand known for its calming products, announces the launch of its XXXXL Calming Dog Bed, specially designed for large breeds and dogs prone to anxiety. The oversized beds, now available in 120cm and 140cm, offer unmatched comfort and emotional relief thanks to premium materials and calming features rooted in behavioral science. Made with ultra-soft vegan faux fur, deep orthopedic padding, and a raised rim for added head and neck support, the XXXXL Calming Bed creates a soothing nest-like environment that helps dogs feel safe, supported, and calm — especially during fireworks, thunderstorms, or when left home alone. 'We've helped over 600,000 dogs sleep better with our calming beds,' says a MrFluffyFriend spokesperson. 'Our community asked for something big enough for their Labradors, Golden Retrievers, Huskies — and we listened. This launch is all about showing that big dogs deserve big comfort, too.' According to veterinarians, over 70% of dogs experience anxiety at some point, which can lead to restlessness, whining, and destructive behavior. MrFluffyFriend's calming design mimics a mother's touch, helping to trigger the release of serotonin and reduce stress naturally. Key Features: Sizes: XXXL (48 in / 120 cm) and XXXXL (56 in / 140 cm) Raised rim for orthopedic support and security Ultra-soft faux fur mimics a mother's touch Machine washable cover + water-resistant, non-slip base Hypoallergenic and pet-safe materials Ideal for large breeds and multi-dog households The launch is accompanied by a limited-time offer of up to 60% off, free shipping across the U.S., and a 30-day risk-free trial, making it easier than ever for pet parents to try the product. Early feedback has been overwhelmingly positive, with customers praising the bed's luxurious size, fluffiness, and noticeable calming effect. Some report their dogs sleep longer, bark less, and even retreat to the bed during stressful moments like vet visits or fireworks. About MrFluffyFriend Founded with a mission to help pets feel safe, calm, and loved, MrFluffyFriend is a pet lifestyle brand trusted by dog lovers in over 25 countries. From calming beds to wellness accessories, every product is developed with science-backed design and premium materials to ensure pets thrive — emotionally and physically. Learn more at Media Contact: Thomas, H. info@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

USA Swimming confirms stomach bug impacting team at worlds
USA Swimming confirms stomach bug impacting team at worlds

Yahoo

timean hour ago

  • Yahoo

USA Swimming confirms stomach bug impacting team at worlds

USA Swimming has confirmed reports that some team members competing in the World Aquatics Championships in Singapore were recovering from acute gastroenteritis, US public broadcaster NPR reported. USA Swimming senior communications director Nikki Warner said in a statement cited by NPR that "those experiencing symptoms" were receiving treatment, without saying which swimmers were affected or how they got sick. The team's medical staff was also "advising the team on further preventative and recovery measures," Warner added. The team is "planning to race and perform to the best of our ability for the rest of the meet," Warner said, according to NPR. Acute gastroenteritis, an inflammation of the stomach and intestines, is usually caused by viruses such as Norovirus or bacteria such as On Saturday, Paris 100 metre butterfly gold medallist Torri Huske did not swim the 100m butterfly "to prioritize her efforts in the 4x100m freestyle relay," USA Swimming said. The relay, which had been favoured to win and was anchored by Huske, came second behind Australia on Sunday evening. Claire Weinstein also pulled out of the 400 metre freestyle. Several US swimmers performed below expectations on Sunday and on Monday morning.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store